Category Archives: Educational Resources

What: Specialty Drug Webinar on Biosimilars When: January 27, 2016 from 2 – 3 PM (EST) Click Here to REGISTER NOW  – Seats are Limited! Join RJ Health for the first in a series of two webinars focusing on Biosimilars and what effect they will have on the Specialty Drug Industry. “Biosimilars – State of […]

ICD-10 is upon us. There was no last ditch effort to block ICD-10 like there has been in the past. The transition from ICD-9 to ICD-10 has happened. As of today, technical implementation of ICD-10 was a success however, many people were not overly excited for ICD-10. Early feedback expressed concern about readiness training, some […]

With only days to go before the ICD-10 deadline, most health plans, PBMs and HMOs are ready. The results of a RJ Health’s survey showed that 59% of respondents are ready for the October 1st transition date. But there are still 41% surveyed who will be playing catch-up past the date, or are not even […]

Two of the key problems facing the specialty drug industry today are: Utilization Management; applying new tools for increasing control over appropriate use, and Drug Selection, also known as Formulary Management; shifting utilization to therapeutic equivalent and more cost effective alternatives. Over 47% of specialty drug utilization is managed by payors under the medical benefit. […]

Specialty drug trend continues to grow at 14-25% annually and it has become the number one drug management priority for payers. Specialty trend is driven primarily by Price, Drug Mix and Utilization and the imminent availability of the ICD-10 data standard creates new opportunities for utilization management programs that can reduce trend up to 7%. […]